Washington H Soul Pattinson & Co. Ltd (ASX: SOL) is an investment house business which has been on the ASX for over a century. Its origins are in owning and operating Australian pharmacies, which is where the Soul Pattinson chemist chain comes from, however, that business is now owned by Australian Pharmaceutical Industries Ltd (ASX: API), which WHSP owns 19.3% of. WHSP invests in a large number of companies across a variety of industries such as construction, resources and telecommunications.
The Washington H. Soul Pattinson and Co. Ltd (ASX:SOL) share price is in focus after reporting its FY25 first-half result.
This is an excellent time to buy ASX passive income stocks due to lower share prices with tariffs affecting the share market.
At times of great ASX share market distress, it can be difficult to stay invested. I’m going to highlight two investments which could make it easier to stay invested through market volatility.
Selfwealth Ltd (ASX: SWF) has now received 2 takeover offers – from Bell Financial Group (ASX: BFG) and Axi. What does that mean to you?
These two ASX dividend shares in this article could be an excellent source of passive income in the coming years.
The Washington H. Soul Pattinson and Co. Ltd (ASX:SOL) share price is in focus after reporting its FY24 result.
Overnight, the US Federal Reserve decided to take the major step of cutting its interest rate by 0.5%. What does this mean for ASX shares?
How does Washington H Soul Pattinson & Co. Ltd (ASX:SOL) actually invest? CEO Todd Barlow sits down with Owen Rask for a deep-dive into the SOL investment process.
There are some great ASX shares that are attractive buys in September 2024. Here are two I’d be willing to buy right now.
